Cargando…
Site of relapse of ductal adenocarcinoma of the pancreas affects survival after multimodal therapy
BACKGROUND: Ductal adenocarcinoma of the pancreas (PDAC) remains one of the most lethal malignancies. To date, no guidelines exists for isolated resectable metachronous disease. It is still unknown, which patients may benefit from relapse surgery. The aim of our study was to compare disease free sur...
Autores principales: | Safi, S. A., Lehwald-Tywuschik, N., Rehders, A., Fluegen, G., Haeberle, L., Keitel, V., Knoefel, W. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931536/ https://www.ncbi.nlm.nih.gov/pubmed/33658016 http://dx.doi.org/10.1186/s12893-021-01082-w |
Ejemplares similares
-
Surgical margin clearance and extended chemotherapy defines survival for synchronous oligometastatic liver lesions of the ductal adenocarcinoma of the pancreas
por: Safi, S. A., et al.
Publicado: (2021) -
Genetic Alterations Predict Long-Term Survival in Ductal Adenocarcinoma of the Pancreatic Head
por: Safi, Sami-Alexander, et al.
Publicado: (2022) -
Optimizing Growth of the Future Liver Remnant and Making In-Situ Liver Transsection Safe—A Standardized Approach to ISLT or ALPPS
por: Alexander, Andrea, et al.
Publicado: (2023) -
Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma
por: Vay, Christian, et al.
Publicado: (2022) -
Pancreatic ductal adenocarcinoma concomitant with pancreatic metastases of clear-cell renal cell carcinoma: a case report
por: Haeberle, Lena, et al.
Publicado: (2021)